Back
Texas Instruments 10K Form
Sell
43
TXN
Texas Instruments
Last Price:
169.78
Seasonality Move:
1.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-07-22 | 10Q | TXN/Texas Instruments Quarterly |
2020-04-22 | 10Q | TXN/Texas Instruments Quarterly |
2020-02-20 | 10K | TXN/Texas Instruments Annual |
2019-10-31 | 10Q | TXN/Texas Instruments Quarterly |
2019-07-31 | 10Q | TXN/Texas Instruments Quarterly |
2019-04-30 | 10Q | TXN/Texas Instruments Quarterly |
Receive TXN News And Ratings
See the #1 stock for the next 7 days that we like better than TXN
TXN Financial Statistics
Sales & Book Value
Annual Sales: | $20.03B |
---|---|
Cash Flow: | $-47M |
Price / Cash Flow: | 49 |
Annual Sales: | $17.56 |
Price / Book: | 9.67 |
Profitability
EPS (TTM): | 8.32000 |
---|---|
Net Income (TTM): | $7.69B |
Gross Margin: | $13.77B |
Return on Equity: | 51.69% |
Return on Assets: | 27.82% |
Texas Instruments Earnings Forecast
Key Texas Instruments Financial Ratios
- The Gross Profit Margin over the past 39 years for TXN is 68.76%.
- The Selling, General & Administrative Expenses for TXN have been equal to 8.51% of Gross Profit Margin.
- The Research & Development expenses have been 8.34% of Revenue.
- The Interest Expense is 2.45% of Operating Income.
- The Net Earning history of TXN is 43.68% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 24 years.
Texas Instruments Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Semiconductors |
Sector: | Technology |
Current Symbol: | TXN |
CUSIP: | 882508 |
Website: | ti.com |
Debt
Debt-to-Equity Ratio: | 0.7 |
---|---|
Current Ratio: | 5.72 |
Quick Ratio: | 4.24 |
Price-to-Earnings
Trailing P/E Ratio: | 18.05 |
---|---|
Forward P/E Ratio: | 20.66 |
TXN Technical Analysis vs Fundamental Analysis
Sell
43
Texas Instruments (TXN)
is a Sell
Is Texas Instruments a Buy or a Sell?
-
Texas Instruments stock is rated a Sell
The current Texas Instruments [TXN] share price is $169.83. The Score for TXN is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.